Lower respiratory tract infection: FDA reporting patterns
44,721 FDA FAERS reports mention Lower respiratory tract infection. 42,160 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 7,697 reports
- Methotrexate: 6,534 reports
- Golimumab: 6,082 reports
- Certolizumab Pegol: 5,597 reports
- Adalimumab: 5,487 reports
- Tocilizumab: 5,422 reports
- Abatacept: 5,297 reports
- Leflunomide: 5,084 reports
- Acetaminophen: 4,873 reports
- Rituximab: 4,748 reports
- Infliximab: 4,390 reports
- Oxycodone: 4,324 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.